Pre-anesthetic Assessment

The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.

Drs. Charles Liu and Jonathan Russin discuss the benefits and potential of fPACT, the alternative to functional MRI.

For patients undergoing curative treatment for lung cancer, coronary artery calcification scoring via computed tomography has a 97 percent likelihood of determining their risk for major cardiovascular events, according to a new meta-analysis.

KA Imaging President and Chief Executive Officer Amol Karnick and Chief Technology Officer Karim S. Karim, Ph.D., offer insights into current X-ray imaging trends, as well as opportunities for innovation.

Reportedly developed on over 90,000 ultrasound exams, the BrightHeart AI software identifies suspicious findings suggestive of congenital heart defects through AI-powered evaluation of fetal heart morphology.

Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.